GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Medivolve MEDVF · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CAD, from our data supplier.

FY2023

Revenue

C$686,500

FY2015FY2023

Net income

−C$16.7m

FY2015FY2023

Free cash flow

−C$2.9m

FY2015FY2023

Shareholders' equity

−C$15.8m

FY2015FY2023

Income statement

Fiscal years

FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
RevenueC$686,500C$1.4mC$86.8mC$10.6m—————
Research and development————C$150,000C$129,800C$718,400C$115,800C$7,500
Operating income−C$3.4m−C$13.1mC$12.4m−C$8.6m−C$2.4m−C$1.0m−C$4.0m−C$868,500−C$989,200
Net income−C$16.7m−C$18.4m−C$6.6m−C$37.8m−C$2.7m−C$711,600C$3.2m−C$761,300−C$1.1m
Diluted earnings per share-0.61-0.67-0.34-0.38-0.08-0.020.09-0.04-0.17

Balance sheet

At each fiscal year end

FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Total assetsC$2.4mC$18.8mC$59.3mC$19.1mC$2.3mC$4.6mC$5.3mC$2.2mC$952,800
Cash and short-term investmentsC$1.0mC$4.3mC$116,700C$1.3mC$767,000C$4.4mC$4.8mC$1.3mC$65,100
Total liabilitiesC$18.1mC$18.5mC$41.5mC$29.1mC$316,000C$35,200C$40,500C$131,800C$1.5m
DebtC$1.7mC$1.6mC$1.8mC$20.2m—————
Shareholders' equity−C$15.8mC$326,300C$17.8m−C$10.0mC$2.0mC$4.5mC$5.3mC$2.1m−C$503,100
Shares outstanding27m27m19m100m34m34m34m19m7m

Cash flow

Fiscal years

FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Cash from operations−C$2.9mC$6.0m−C$9.3m−C$11.0m−C$4.4m−C$384,000C$3.5m−C$1.1m−C$169,200
Capital spending——−C$42,700−C$414,000—−C$75,000−C$25,000−C$10,600—
Free cash flow−C$2.9mC$6.0m−C$9.4m−C$11.4m−C$4.4m−C$459,000C$3.5m−C$1.1m−C$169,200

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-59.8%——
Operating income-26.7%27.3%—
Net income-23.9%87.9%—

Share price return

Finished calendar years

20252024
Return33%126%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 15-to-1 reverse split · 8 Dec 2022
  • 10-to-1 reverse split · 23 Oct 2015

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.